Ten Largest Investments

Summary by AI ^BETAClose X

JPMorgan India Growth & Income PLC has announced its ten largest investments as a percentage of total assets as of November 28, 2025. Hdfc Bank Ltd represents the largest holding at 9.8%, followed by Icici Bank Ltd at 9.2%, and Mahindra & Mahindra Ltd at 5.1%. Kotak Mahindra Bank Ltd, Reliance Industries Ltd, Dr Reddy'S Laboratories Ltd, ITC Ltd, Tata Consultancy Services Ltd, Bajaj Finserv Ltd, and Cholamandalam Investment and Finance Co Ltd make up the remainder of the top ten, with holdings ranging from 4.8% down to 2.6%. These top ten investments collectively account for 49.5% of the Company's total assets, excluding liquidity stocks.

Disclaimer*

JPMorgan India Growth & Income PLC

10 December 2025


JPMORGAN INDIA GROWTH & INCOME PLC (the 'Company')
Legal Entity Identifier: 549300OHW8R1C2WBYK02
THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 28 November 2025
Hdfc Bank Ltd	9.8%
Icici Bank Ltd	9.2%
Mahindra & Mahindra Ltd	5.1%
Kotak Mahindra Bank Ltd	4.8%
Reliance Industries Ltd	4.6%
Dr Reddy'S Laboratories Ltd	3.6%
Itc Ltd	3.4%
Tata Consultancy Services Ltd	3.2%
Bajaj Finserv Ltd	3.1%
Cholamandalam Investment and Finance Co Ltd	2.6%
Total	49.5%
Excludes Investments in Liquidity stocks
Name of contact and telephone number for queries:
Paul Ainger 0044 207 742 6524
Name of authorised company official responsible for making this notification:
Sachu Saji 0800 20 40 20 - Company Secretary
Date: 10 December 2025

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END